Other Open Access

Treating non-small cell lung cancer: What do patients PREFER

Meredith Smith; Serena Oliveri; Monica Casiraghi

BibTeX Export

@misc{meredith_smith_2022_6260511,
  author       = {Meredith Smith and
                  Serena Oliveri and
                  Monica Casiraghi},
  title        = {{Treating non-small cell lung cancer: What do 
                   patients PREFER}},
  month        = feb,
  year         = 2022,
  publisher    = {Zenodo},
  doi          = {10.5281/zenodo.6260511},
  url          = {https://doi.org/10.5281/zenodo.6260511}
}
185
120
views
downloads
All versions This version
Views 185185
Downloads 120120
Data volume 95.4 MB95.4 MB
Unique views 169169
Unique downloads 106106
More info on how stats are collected.
Indexed in
Publication date:
February 24, 2022
DOI:
10.5281/zenodo.6260511

Zenodo DOI Badge

DOI 

10.5281/zenodo.6260511

Markdown 

[![DOI](https://zenodo.org/badge/DOI/10.5281/zenodo.6260511.svg)](https://doi.org/10.5281/zenodo.6260511)

reStructedText 

.. image:: https://zenodo.org/badge/DOI/10.5281/zenodo.6260511.svg
   :target: https://doi.org/10.5281/zenodo.6260511

HTML 

<a href="https://doi.org/10.5281/zenodo.6260511"><img src="https://zenodo.org/badge/DOI/10.5281/zenodo.6260511.svg" alt="DOI"></a>

Image URL 

https://zenodo.org/badge/DOI/10.5281/zenodo.6260511.svg

Target URL 

https://doi.org/10.5281/zenodo.6260511

Keyword(s):
Plain language summary Case study
Grants:
European Commission:
  • PREFER - Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 (115966)
Communities:
License (for files):
Creative Commons Attribution 4.0 International

Versions

Version 1 10.5281/zenodo.6260511 Feb 24, 2022
Cite all versions? You can cite all versions by using the DOI 10.5281/zenodo.6260510. This DOI represents all versions, and will always resolve to the latest one. Read more.

Share

Cite as

Export